Brought to you by 
Ilypsa raises $36mm with Series B venture round
Aug 2005
Executive Summary
Biopharmaceutical company Ilypsa (formerly Symyx Therapeutics, a 2003 spin-out from Symyx Technologies) raised $36mm in a Series B round co-led by new investors US Venture Partners, Johnson & Johnson Development Corp., and Delphi Ventures. Also participating in the financing were other new investors CMEA Ventures and Mediphase Venture Partners, along with existing backers Sprout Group and 5AM Ventures.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ilypsa raises $36mm with Series B venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice